Clinical Trial Update: Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis [NA]

View source ↗

Summary

Pilot study assessing the effect of nicotinamide riboside on immune activation in psoriasis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Psoriasis

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Psoriasis, Atherosclerotic Cardiovascular Disease | NA | Status: COMPLETED | Results posted: 2023-12-27